Ronda Scott v. Advanced Pharmaceutical Consultants Inc, et al., No. 21-14214 (11th Cir. 2023)
Annotate this Case
The case at hand is about whether Plaintiff was retaliated against by her former employer, Advanced Pharmaceutical Consultants, Inc. (“APC”), and the company that contracted with her employer, Centurion of Florida, LLC (“Centurion”) (together, “Defendants”), for engaging in protected activity. Plaintiff’s complaint alleged four counts. Centurion and APC both moved for summary judgment on all counts. The district court granted summary judgment on three of them. The district court directed the clerk to enter a final judgment on the three resolved counts, and it certified that the fourth count satisfied the requirements of 28 U.S.C. Section 1292(b) for immediate interlocutory review, should either party file an appropriate application with the Eleventh Circuit. At issue is whether the district court’s certification was proper as to Plaintiff’s direct appeal and whether the requirements of 28 U.S.C. Section 1292(b) have been met as to Centurion’s cross-appeal.
The Eleventh Circuit concluded that the answer to both questions is not and dismissed the appeals for lack of appellate jurisdiction. The court explained that there are substantial reasons to delay resolving Plaintiff’s appeal of her whistleblower counts against APC. Plaintiff’s whistleblower counts against Centurion and APC are identical. It makes good sense that appeals of an order dismissing those counts should be heard together. But because there is no final judgment against Centurion, the court wrote that it lacks the power to adjudicate those counts against Centurion at this time.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.